Navigation Links
GENEWIZ To Launch Single-Cell RNA-Seq Services At AACR

SOUTH PLAINFIELD, N.J. and WASHINGTON, March 28, 2017 /PRNewswire/ -- (AACR17, Booth #3431) – Leading global genomics service provider, GENEWIZ, will launch single-cell sequencing during the American Association for Cancer Research (AACR) Annual Meeting at the Walter E. Washington Convention Center in Washington, D.C., April 1-5, 2017. Single-Cell RNA-Seq allows researchers to perform differential gene expression of thousands of cells at the individual level.


  • Experts on-hand at AACR to discuss expanded next generation sequencing service offerings for cancer researchers including single-cell sequencing with the 10x Genomics® Chromium™, and whole genome sequencing with the Illumina HiSeq™ X Ten and the PacBio® Sequel.
  • Show-only discounts on GENEWIZ's complete service offering including: next generation and Sanger sequencing, gene synthesis, and GLP-compliant services.
  • Poster presentation in conjunction with Celsee Diagnostics:
    "Enrichment and Mutation Detection of Circulating Tumor Cells from Blood Samples"
    Liquid Biopsies 1: Circulating Tumor Cells
    Monday, April 3 -- 8 a.m. to Noon
    Poster Section 30 / Poster Board 10
Continue Reading

"We are excited to introduce our new single-cell sequencing workflow at AACR as it will bring cancer researchers complete access to critical molecular information down to the cellular level," said Dr. Ginger Zhou, director of genomics and molecular genetics, GENEWIZ. "AACR brings together the best and the brightest in cancer research, making it an excellent opportunity for us to collaborate on new technologies and proprietery protocols that will help scientists advance their discoveries faster than ever before and ultimately transform cancer genomics."

GENEWIZ is a global leader in genomics services that enable research scientists within pharmaceutical, biotechnology, agriculture, environmental and clean energy, academic, and government institutions to advance their discoveries. Customers rely on our unique and proprietary genomics technologies and services, backed by our specialized experts in DNA sequencing, gene synthesis, molecular biology, high throughput sequencing, bioinformatics, and GLP regulatory-compliant services.

Headquartered in South Plainfield, NJ, GENEWIZ is privately-held with a global network of laboratories in Boston, MA; Washington, D.C. Metro; Research Triangle Park, NC; San Diego, CA; Los Angeles, CA; San Francisco, CA; and Seattle, WA. International locations include Beijing, Suzhou, and Tianjin, China; Takeley, United Kingdom; and Tokyo, Japan.  For more information, visit, and connect with us on LinkedIn, Twitter, Facebook, YouTube, WeChat, and Weibo.

To view the original version on PR Newswire, visit:

Copyright©2017 PR Newswire.
All rights reserved

Related biology technology :

1. GENEWIZ Chosen For The Inc. 5000 List Of Fastest-Growing Private Companies For Third Year In A Row
2. Global Genomics Company, GENEWIZ, Receives Investment
3. Sigma-Aldrich Collaborates with GENEWIZ and Oxford Genetics to Speed Ordering Process for DNA Services
4. GENEWIZ Joins Inc. 5000 List of Fastest-growing Private Companies for Second Consecutive Year
5. GENEWIZ to Present at PEGS Europe Protein & Antibody Summit
6. Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz
7. Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz
8. Research and Markets Has Announced the Launch of Their Valero Energy Market Research Portal
9. DarioHealth Launches Insurance Coverage Option for U.S. Consumers
10. SeraCare Life Sciences announces launch of industrys first multiplexed Inherited Cancer reference material
11. Easy-to-Use Vertical Garden EcoQube Frame, for Growing Micro-Veggies Indoors Quickly and Affordably, Crushes Crowdfunding Goal Minutes After Launch
Post Your Comments:
(Date:10/12/2017)... ... 12, 2017 , ... BioMedGPS announces expanded coverage of SmartTRAK ... module, US Hemostats & Sealants. , SmartTRAK’s US Market for Hemostats and Sealants ... sealants and biologic sealants used in surgical applications. BioMedGPS estimates the market will ...
(Date:10/11/2017)... , ... October 11, 2017 , ... ... President Andi Purple announced Dr. Suneel I. Sheikh, the co-founder, CEO and ... Labs ), Inc. has been selected for membership in ARCS Alumni Hall ...
(Date:10/11/2017)... ... , ... ComplianceOnline’s Medical Device Summit is back for its 4th year. The ... Francisco, CA. The Summit brings together current and former FDA office bearers, regulators, industry ... officials from around the world to address key issues in device compliance, quality and ...
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017  SkylineDx ... London (ICR) and University of Leeds ... to risk-stratify patients with multiple myeloma (MM), in a multi-centric ... The University of Leeds is the ... UK, and ICR will perform the testing services to include ...
Breaking Biology Technology:
(Date:4/5/2017)... , April 5, 2017  The Allen Institute for ... Cell Explorer: a one-of-a-kind portal and dynamic digital window ... imaging data, the first application of deep learning to ... stem cell lines and a growing suite of powerful ... for these and future publicly available resources created and ...
(Date:3/30/2017)... LOS ANGELES , March 30, 2017  On ... Hack the Genome hackathon at ... This exciting two-day competition will focus on developing health ... experience. Hack the Genome is ... has been tremendous. The world,s largest companies in the ...
(Date:3/27/2017)... , March 27, 2017  Catholic Health ... and Management Systems Society (HIMSS) Analytics for achieving ... Adoption Model sm . In addition, CHS previously ... U.S. hospitals using an electronic medical record (EMR). ... its high level of EMR usage in an ...
Breaking Biology News(10 mins):